Back
Amicus Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
25
FOLD
Amicus Therapeutics
Last Price:
$6.02
Seasonality Move:
23.08%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.22 | Sell |
| 20-day SMA: | 6.74 | Sell |
| 50-day SMA: | 7.68 | Sell |
| 200-day SMA: | 9.7 | Sell |
| 8-day EMA: | 6.28 | Sell |
| 20-day EMA: | 6.69 | Sell |
| 50-day EMA: | 7.48 | Sell |
| 200-day EMA: | 9.24 | Sell |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.44 | Sell |
| Relative Strength Index (14 RSI): | 32.18 | Sell |
| Chaikin Money Flow: | -3427933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.25 - 7.19) | Sell |
| Bollinger Bands (100): | (7.39 - 9.81) | Sell |
Amicus Therapeutics Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.02 while FOLD 8-day simple moving average is 6.22, which is a Sell signal.
-
The stock price of FOLD is 6.02 while Amicus Therapeutics 20-day SMA is 6.74, which makes it a Sell.
-
Amicus Therapeutics 50-day simple moving average is 7.68 while FOLD share price is 6.02, making it a Sell technically.
-
FOLD stock price is 6.02 and Amicus Therapeutics 200-day simple moving average is 9.70, creating a Sell signal.
FOLD Technical Analysis vs Fundamental Analysis
Sell
25
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a SellThe current Amicus Therapeutics [FOLD] share price is $6.02. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
1.9B
Price in USD:
6.02
Share Volume:
3.8M
Amicus Therapeutics 52-Week Range
52-Week High:
12.65
52-Week Low:
5.82
Sell
25
Amicus Therapeutics (FOLD)
is a Sell
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?The Amicus Therapeutics stock price is 6.02 USD today.
-
Will FOLD stock go up or go down?Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Amicus Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is overvalued.
Is Amicus Therapeutics Stock a Buy?
-
Amicus Therapeutics share price is 6.02 while FOLD 8-day exponential moving average is 6.28, which is a Sell signal.
-
The stock price of FOLD is 6.02 while Amicus Therapeutics 20-day EMA is 6.69, which makes it a Sell.
-
Amicus Therapeutics 50-day exponential moving average is 7.48 while FOLD share price is 6.02, making it a Sell technically.
-
FOLD stock price is 6.02 and Amicus Therapeutics 200-day simple moving average is 9.24, creating a Sell signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.47 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
-
FOLD Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Amicus Therapeutics is a Sell
-
Amicus Therapeutics Relative Strength Index (RSI) is 32.18, which suggest Amicus Therapeutics is oversold
-
The Bollinger Bands (25) for Amicus Therapeutics is (6.25 - 7.19), which suggest Amicus Therapeutics is a Sell
-
The Bollinger Bands (100) for Amicus Therapeutics is (7.39 - 9.81), which suggest Amicus Therapeutics is a Sell
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.